Treating rheumatoid arthritis to target: recommendations of an international task force
…, M Schoels, D Van Der Heijde - Annals of the …, 2010 - ard.bmj.com
Background Aiming at therapeutic targets has reduced the risk of organ failure in many
diseases such as diabetes or hypertension. Such targets have not been defined for rheumatoid …
diseases such as diabetes or hypertension. Such targets have not been defined for rheumatoid …
[HTML][HTML] Infliximab and methotrexate in the treatment of rheumatoid arthritis
PE Lipsky, DMFM van der Heijde… - … England Journal of …, 2000 - Mass Medical Soc
Background Neutralization of tumor necrosis factor α (TNF-α) for three to six months reduces
the symptoms and signs of rheumatoid arthritis. However, the capacity of this approach to …
the symptoms and signs of rheumatoid arthritis. However, the capacity of this approach to …
Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial
A Wanders, D Heijde, R Landewé… - Arthritis & …, 2005 - Wiley Online Library
Objective A 2‐year randomized controlled trial was performed to test the hypothesis that
long‐term, continuous treatment with nonsteroidal antiinflammatory drugs (NSAIDs), in …
long‐term, continuous treatment with nonsteroidal antiinflammatory drugs (NSAIDs), in …
Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double‐blind, placebo‐controlled, phase III trial
RD Inman, JC Davis Jr, DVD Heijde… - … : Official Journal of …, 2008 - Wiley Online Library
Objective To evaluate the efficacy and safety of golimumab in patients with ankylosing
spondylitis (AS) in the GO‐RAISE study. Methods Patients with active AS, a Bath AS Disease …
spondylitis (AS) in the GO‐RAISE study. Methods Patients with active AS, a Bath AS Disease …
Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis
D Heijde, R Landewé, X Baraliakos… - … : Official Journal of …, 2008 - Wiley Online Library
… Désirée van der Heijde … van der Heijde had full access to all of the data in the study
and takes responsibility for the integrity of the data and the accuracy of the data analysis. …
and takes responsibility for the integrity of the data and the accuracy of the data analysis. …
Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double‐blind, placebo‐controlled trial
D van der Heijde, A Kivitz, MH Schiff… - … : Official Journal of …, 2006 - Wiley Online Library
Objective To evaluate the safety and efficacy of adalimumab, a fully human recombinant IgG1
monoclonal antibody that specifically targets human tumor necrosis factor, in patients with …
monoclonal antibody that specifically targets human tumor necrosis factor, in patients with …
Determination of the minimal clinically important difference in rheumatoid arthritis joint damage of the Sharp/van der Heijde and Larsen/Scott scoring methods by …
K Bruynesteyn, D van der Heijde… - … : Official Journal of …, 2002 - Wiley Online Library
… the SDD (5.0) of the Sharp/van der Heijde method as minimal clinically important, resulting
in … This study suggests that the SDD of the Sharp/van der Heijde method can be used as the …
in … This study suggests that the SDD of the Sharp/van der Heijde method can be used as the …
Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial
JC Davis Jr, D Van Der Heijde, J Braun… - Arthritis & …, 2003 - Wiley Online Library
Objective To determine the safety and efficacy of etanercept in a multicenter, randomized,
placebo‐controlled, double‐blind trial of adults with moderate to severe active ankylosing …
placebo‐controlled, double‐blind trial of adults with moderate to severe active ankylosing …
Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo‐controlled trial (ASSERT)
D van der Heijde, B Dijkmans… - … : Official Journal of …, 2005 - Wiley Online Library
… van der Heijde gave expert testimony at the FDA hearing on inhibition of structural damage
and received a fee from Centocor, Inc. Drs. DeWoody and Williamson own stock in Johnson …
and received a fee from Centocor, Inc. Drs. DeWoody and Williamson own stock in Johnson …
Combined spa–exercise therapy is effective in patients with ankylosing spondylitis: a randomized controlled trial
…, R Landewé, D Van Der Heijde… - Arthritis Care & …, 2001 - Wiley Online Library
Objective To determine the efficacy of combined spa–exercise therapy in addition to
standard treatment with drugs and weekly group physical therapy in patients with ankylosing …
standard treatment with drugs and weekly group physical therapy in patients with ankylosing …